(Q40441736)
Statements
Basiliximab combined with low-dose rabbit anti-human thymocyte globulin: a possible further step toward effective and minimally toxic T cell-targeted therapy in kidney transplantation (English)
Piero Ruggenenti
Annalisa Perna